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Numerous studies have reported increases in asthma prevalence among children world-wide. Less is known about
similar trends in adults. We aimed to investigate whether the prevalence of allergic asthma symptoms had increased
in an adult general population.
Two cross-sectional surveys using identical methods were carried out in 1989 and 1998. A one-page questionnaire
on respiratory symptoms was mailed to random samples of 15–41-year-olds living in Copenhagen. The response
rates were 86?6% (3624/4185) and 78?8% (2402/3048) in 1989 and 1998, respectively. The questionnaire was
validated with specific immunoglobilin E (IgE) positivity as the reference in a random sample of responders in
connection with both surveys.
We found a significantly increased prevalence of subjects who reported shortness of breath on exposure to
pollens (6?6% vs. 10?3%, odds ratio 1?61, 95% CI 1?34–1?95), furry animals (5?4% vs. 7?6%, odds ratio 1?45, 95%
CI 1?17–1?79), and house dust (7?8% vs. 10?2%, odds ratio 1?35, 95% CI 1?12–1?61). The validation of these
symptoms showed that the positive predictive values were reasonably stable over time, which may support that a
true increase in allergic asthma has occurred.
In conclusion, the prevalence of allergic asthma symptoms increased significantly in this adult general population
over a 9-year period.
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There is evidence that the prevalence of asthma has
increased in children in many countries (1–4). Less is
known about similar trends in adult populations (5). It has
not yet been possible to develop a simple objective
diagnostic test for asthma (6), and most studies of trends
of asthma prevalence have defined asthma as self-reported
diagnosed asthma or self-reported asthma symptoms (7).
However, concurrent with the reported increases in asthma
prevalence the recognition of asthma is likely to have
increased as well (1,2,3,9). This would tend to over-estimate
increases in asthma prevalence when self-reported diag-
nosed asthma is used in time trend studies. Assessment of
asthma symptoms may not to the same degree be
susceptible to changes in the labelling of asthma (5), and
questionnaires on asthma symptoms therefore remain theCorrespondence should be addressed to: Allan Linneberg, MD,
Centre for Preventive Medicine, Glostrup Hospital, 7 Ndr.
Ringvej, Entrance 8, 7th Floor, DK-2600 Glostrup, Denmark.
Fax: 45 4323-3977; E-mail: alli@glostruphosp.dk
0954-6111/01/040258+07 $35?00/0cornerstone of large-scale epidemiological studies (10).
Nevertheless, the awareness of asthma symptoms may also
change over time, and it would therefore be appropriate to
validate asthma symptom questionnaires in relation to
objective measures.
The aim of the present study was to investigate whether
the prevalence of allergic asthma symptoms had increased
in an adult general population over a 9-year period. The
questionnaire employed was validated in relation to specific
immunoglobulin E (IgE) positivity at both cross-sectional
surveys in the beginning and at the end of the period. We
also investigated the association between rhinitis and
asthma related to exposure to the same group of allergens.
Methods
SUBJECTS AND DESIGN
This study is based on two cross-sectional surveys in 1989
and 1998 using the same sampling frame and method. An
identical one-page questionnaire on respiratory symptoms# 2001 HARCOURT PUBLISHERS LTD
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the western part of Copenhagen County (Denmark), which
is an urban area with a high prevalence of self-reported
asthma compared to rural areas in Denmark (11). Citizen-
ship (Danish) and birthplace (Denmark) further restricted
the samples. In both surveys, the questionnaire was mailed
in November (autumn; out of the pollen season) and
followed, if necessary, by two reminders.
QUESTIONNAIRE AND DEFINITIONS
The questionnaire comprised questions on upper and lower
airway symptoms on exposure to three different groups of
aeroallergens: pollen, animal dander and dust mite (ques-
tions b and f; c and g; d and h in Table 1). In addition,
questions on lower airway symptoms considered non-
allergic in nature were included (questions e and i–k in
Table 1).
Based on symptoms reported in the questionnaire the
following ‘diagnoses’ of allergic rhinitis and allergic asthma
were defined: ‘rhinitis related to pollen exposure (‘yes’ to
question b) and ‘asthma related to pollen exposure’ (‘yes’ to
question f); ‘rhinitis related to dander exposure’ (‘yes’
to question c) and ‘asthma related to dander exposure’
(‘yes’ to question g); ‘rhinitis related to mite exposure’
(‘yes’ to question d) and ‘asthma related to mite exposure’
(‘yes’ to question h). Furthermore, for the above diagnoses
of allergic asthma the corresponding 12-month period
prevalences were defined by combining these symptoms
with symptom e (‘shortness of breath when at rest at any
time in last 12 months’). For example, if the answers to
question e and question f were both ‘yes’, ‘asthma related to
pollen exposure’ was considered present within the last 12
months.
VALIDATION OF THE QUESTIONNAIRE IN
1990 AND 1998
The questionnaire was validated in relation to specific
IgE positivity to common aeroallergens in a random
sample of responders to the questionnaire in connection
with both surveys. The study populations and
methods have previously been described in more detail
(12). Briefly, in 1990 and 1998, random samples of 312
and 482 responders to the questionnaire participated in a
health examination including blood sample drawing.
Serum samples from the participants were analysed
for specific IgE to birch, grass, mugwort, dog and cat
dander, and house dust mite (D. pteronyssinus) using the
ADVIA1 CentaurTM Specific IgE assay system (Bayer
Corporation). The analysis for specific IgE was judged to
be positive if the measurement of specific IgE was in excess
of 0?35 kU l71.
Sensitivity was defined as the proportion of subjects
reporting a given symptom among all those with a positive
test for specific IgE to the relevant allergen(s). Specificity
was defined as the proportion of subjects without a given
symptom among those with a negative test for specific
IgE to the relevant allergen(s). The positive predictivevalue was defined as the proportion of subjects specific-
IgE-positive to relevant allergen(s) among those reporting
a given symptom.
STATISTICAL ANALYSIS
Three age groups were defined: 15–23 years, 24–32 years
and 33–41 years. The changes in the prevalence of
symptoms were expressed by odds ratios comparing the
second to the first survey. The odds ratios were adjusted for
differences in the distribution on sex and age group in a
logistic regression model. Test for homogeneity of the odds
ratios by age group (or sex) was done by testing for
interaction between survey and age group (or sex). All data
were analysed using the Statistical Products and Service
Solutions package (SPSS) for Windows (Release 8.0).
Results
The response rates were 86?6% (3624/4185) and 78?8%
(2402/3048) in 1989 and 1998, respectively. In both surveys,
the prevalence of missing answers was less than 1?4% for all
questions. The prevalence of ‘asthma related to pollen
exposure’, ‘asthma related to dander exposure’, and
‘asthma related to mite exposure’ increased significantly
(symptoms f–h in Table 1). In contrast, the prevalence of
lower airway symptoms of a more general nature, i.e. non-
allergic, were virtually unchanged (symptoms e and i–k in
Table 1). In addition, ‘rhinitis related to pollen exposure’
‘rhinitis related to dander exposure’, and ‘rhinitis related to
mite exposure’ showed very similar and significant increases
(symptoms b–d in Table 1). Among the symptoms that
increased significantly, ‘rhinitis related to dander exposure’,
‘rhinitis related to mite exposure’ and ‘asthma related to
mite exposure’ increased significantly more among males
than among females. The prevalence of these symptoms
were significantly lower among men in the first survey,
but these differences thus diminished in the second
survey. The observed increases did not show any significant
trend in relation to age. Nor was this the case when
data was analysed in men and women separately. Thus,
allergic rhinitis and allergic asthma symptoms increased
similarly in the three age groups. Table 2 shows that similar
and significant increases were observed for the correspond-
ing 12-month period prevalence of the allergic asthma
symptoms.
The validation of the questions on allergic asthma
symptoms with specific IgE as the reference in random
samples of responders in 1990 and 1998 is shown in Table 3.
It shows that the sensitivity tended to increase, while the
specificity tended to decrease, from 1990 to 1998. In
contrast, the positive predictive values were reasonably
stable over time.
Table 4 shows the relationship between asthma
and rhinitis related to exposure to the same group
of allergens. Thus, the frequency of allergic asthma
among subjects with allergic rhinitis was 40–50%,
whereas the frequency of allergic asthma among subjects
without allergic rhinitis was 1% or less. Consequently,
TABLE 1. Prevalence of reported symptoms in 1989 and 1998
Question (symptom) 1989 prevalence 1998 prevalence Odds ratio{ (95% CI)
(a) Itchy or stuffy nose or sneezing during summer months 22?3 (805/3604) 28?6 (686/2395) 1?40 (1?24–1?57)*
(b) Itchy or stuffy nose or sneezing when near grass, trees or flowers 17?1 (614/3601) 25?3 (605/2393) 1?66 (1?46–1.88)*
(c) Itchy or stuffy nose or sneezing when near furry animals 10?2 (369/3607) 14?4 (346/2395) 1?51 (1?29–1?76)*
(d) Itchy or stuffy nose or sneezing when cleaning rooms or making beds, or when in bed 19?1 (687/3605) 23?9 (571/2393) 1?34 (1?18–1.52)*
(e) Shortness of breath when at rest at any time in last 12 months 14?4 (520/3608) 15?3 (366/2396) 1?05 (0?91–1.22)
(f) Shortness of breath when near grass, trees or flowers 6?6 (236/3579) 10?3 (245/2379) 1?61 (1?34–1.95)*
(g) Shortness of breath when near furry animals 5?4 (192/3576) 7?6 (181/2379) 1?45 (1?17–1?79)*
(h) Shortness of breath when cleaning rooms or making beds, or when in bed 7?8 (279/3572) 10?2 (243/2377) 1?35 (1?12–1?61)*
(i) Shortness of breath when hurrying on level ground or walking up slight hill 24?0 (862/3594) 24?2 (579/2396) 1?01 (0?89-1?14)
(j) Shortness of breath when walking with other people of your own age on level ground 4?4 (159/3607) 5?1 (121/2395) 1?13 (0?88–1?44)
(k) Having to stop for breath when walking at your own pace on level ground 2?4 (87/3610) 2?8 (67/2397) 1?13 (0?81–1?56)
*P5 0?05.
{Sex- and age-adjusted odds ratios comparing the prevalence in 1998 to that in 1989.
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TABLE 2. The 12-month period prevalence of asthma related to pollen, dander or mite exposure in 1989 and 1998
1989
prevalence
1998
prevalence
Odds ratio{ (95% CI)
‘Asthma related to pollen exposure’ within 12 months
(symptoms e and f combined)
3?9 (138/3579) 5?7 (136/2379) 1?49 (1?16–1.90)*
‘Asthma related to dander exposure’ within 12 months
(symptoms e and g combined)
3?6 (128/3576) 4?9 (117/2379) 1?39 (1?07–1?80)*
‘Asthma related to mite exposure’ within 12 months
(symptoms e and h combined)
4?6 (166/3572) 6?2 (148/2377) 1?35 (1?07–1?69)*
*P50?05.
{Sex- and age-adjusted odds ratios comparing the prevalence in 1998 to that in 1989.
Symptom e: ‘shortness of breath when at rest at any time in last 12 months’.
Symptom f: ‘shortness of breath when near grass, trees or flowers’.
Symptom g: ‘shortness of breath when near furry animals’.
Symptom h: ‘shortness of breath when cleaning rooms or making beds, or when in bed’.
TABLE 3. Results of the validation of questions on allergic asthma symptoms in relation to specific IgE positivity (reference) in
two random samples of 15–41-year-olds in 1990 (n312) and 1998 (n482)
Sensitivity (%) Specificity
(%)
Positive predic-
tive value (%)
Odds ratio (95% CI){
1990 1998 1990 1998 1990 1998 1990 1998
Symptom f vs. specific IgE to
birch, grass, or mugwort
19?4 27?7 97?9 94?3 70?6 63?5 18?4 (5?5–61?2) 7?1?(3?8–13?5)
Symptom g vs. specific IgE to
cat or dog
20?8 32?1 97?1 94?0 38?5 42?9 11?2 (2?9–43?7) 8?5 (4?1–17?6)
Symptom h vs. specific IgE to
D. pteronyssinus
22?2 23?6 94?4 88?6 20?0 21?7 3?5 (1?0–13?1) 2?5 (1?2–5?1)
{The association between the symptom and specific IgE positivity expressed as sex- and age-adjusted odds ratio.
Symptom f: ‘shortness of breath when near grass, trees or flowers’.
Symptom g: ‘shortness of breath when near furry animals’.
Symptom h: ‘shortness of breath when cleaning rooms or making beds, or when in bed’.
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rhinitis was up to 300 times that among subjects without
allergic rhinitis.
Discussion
We found a significantly increased prevalence of allergic
asthma symptoms in this adult general population. The
previously reported increase in the prevalence of specific
IgE to common aeroallergens in our background popula-
tion (12) therefore appear to coincide with an increase in
asthma symptoms related to allergen exposure. Further-
more, this increase is in keeping with numerous studies,
mainly in children, that have reported increasing preva-
lences of asthma and asthma symptoms (7). Our results
suggest that in these populations increases in asthma
prevalence may now also be apparent among adults.We defined allergic asthma as a history of shortness of
breath on exposure to allergens. This may not accurately
reflect allergic asthma. Most trend studies of asthma
symptom prevalence have employed questions on ‘wheez-
ing’, which is not a commonly used phrase in Denmark.
Therefore, caution should exercised when comparing the
prevalence rates and increases of asthma symptoms
observed in this study to those observed in other studies.
The reported increases in prevalence of asthma are likely
to be due to changes in environmental or lifestyle factors
(5). If these risk factors operated in early childhood only,
changes in prevalence would be apparent, at first, among
the youngest subjects in our population reflecting a cohort
effect. However, we observed no such age-related trend, and
this may suggest that some of these risk factors operate in
adulthood as well as in childhood. However, we do not
know whether the age range of the study population was
appropriate for detecting a possible cohort effect.
TABLE 4. The relationship between asthma and rhinitis related to exposure to the same group of allergens
1989 1998
Pollen allergy
Frequency of ‘asthma related to pollen exposure’
among subjects with ‘rhinitis related to pollen exposure’
37?5% (228/608) 40?6% (242/596)
Frequency of ‘asthma related to pollen exposure’
among subjects without ‘rhinitis related to pollen exposure’
0?2% (7/2959) 0?1% (2/1779)
Risk of ‘asthma related to pollen exposure’ associated
with ‘rhinitis related to pollen exposure’{
158?5 (118?4–540?8) 361?2 (90?1–1447?9)
Animal dander allergy
Frequency of ‘asthma related to dander exposure’
among subjects with ‘rhinitis related to dander exposure’
51?5% (186/361) 51?9% (176/339)
Frequency of ‘asthma related to dander exposure’
among subjects without ‘rhinitis related to dander exposure’
0?2% (6/3210) 0?2% (5/2038)
Risk of ‘asthma related to dander exposure’ associated
with ‘rhinitis related to dander exposure’{
275?7 (123?2–616?9) 211?6 (87?7–510?9)
Mite allergy
Frequency of ‘asthma related to mite exposure’
among subjects with ‘rhinitis related to mite exposure’
37?3% (250/671) 40?1% (225/561)
Frequency of ‘asthma related to mite exposure’
among subjects without ‘rhinitis related to mite exposure’
1?0% (29/2894) 1?0% (18/1813)
Risk of ‘asthma related to mite exposure’ associated
with ‘rhinitis related to mite exposure’{
37?2 (25?5–54?1) 40?4 (25?2–64?7)
{Risk ratio, i.e. frequency of asthma among subjects with rhinitis divided by the frequency of asthma among subjects without
rhinitis (95% CI).
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the observed increase in the prevalence of allergic asthma
symptoms. Firstly, non-respondence could bias the results.
The response rates were reasonably similar, although lower
in the 1998 survey. Telephone interviews have previously
been conducted in non-responders to the same mailed
questionnaire in the same background population, and the
prevalence of allergic asthma symptoms were similar
among responders and non-responders (13). Consequently,
it seems unlikely that non-respondence could substantially
bias the results. Secondly, the pollen seasons preceding the
two surveys showed only minor differences when compar-
ing the cumulated pollen count in Copenhagen during the
1989 and 1998 pollen seasons (14). Thirdly, the validity,
and possible changes in the validity, of the questionnaire,
should be considered. The questionnaire was validated with
specific IgE positivity as the reference in 1990 and again in
1998. The validation of the questions on allergic rhinitis
symptoms has previously been reported (12), and it showed
that the sensitivity tended to increase, while the specificity
tended to decrease from 1990 to 1998. As shown in Table 3,
this is also the case for the questions on allergic asthma
symptoms. Thus, it seems that the proportion of specific
IgE-positive subjects who report allergic asthma symtoms
has increased, which may indicate increased awareness/perception of symptoms or increased morbidity among
specific IgE-positive subjects. In contrast, the postive
predictive values of symptoms were reasonably stable over
time, which may support that the observed increase in
allergic asthma symptom prevalence reflects a true increase
in allergic asthma prevalence. The positive predictive values
are dependent on the prevalence of sensitization, which has
increased in our study population from 1990 to 1998 (12).
This increase may explain that the positive predictive values
were reasonably stable despite a decrease in the specificity
of symptoms.
Allergic rhinitis and allergic asthma often co-exist (15–
18). The similarities between allergic rhinitis and asthma
outweigh the differences, and they are linked by epidemio-
logical, histological, physiological, and immunopathologi-
cal characteristics (18). They are also linked from a
therapeutic point of view. Thus, specific immunotherapy
improves co-existing asthma in pollen rhinitis patients and
may prevent development of asthma in children with pollen
rhinitis (19,20), and pharmacological treatment improves
co-existing asthma in allergic rhinitis patients (16). The
observed associations between rhinitis and asthma related
to the same group of allergens was remarkably strong
(Table 4). For example, ‘asthma related to pollen exposure’
was almost non-existent among subjects without ‘rhinitis
SECULAR TRENDS OF ALLERGIC ASTHMA IN DANISH ADULTS 263related to pollen exposure’ (Table 4), and accordingly
almost 100% of subjects with ‘asthma related to pollen
exposure’ reported ‘rhinitis related to pollen exposure’.
Consistent with this, it has been reported that 98?9% (360/
364) of allergic asthmatics had rhinitis in addition (21).
These findings suggest that pollen rhinitis precedes, or
develops concurrently with, pollen asthma, which lend
support to the hypothesis that allergic rhinitis and allergic
asthma may be manifestations of the same disease entity.
The proportion of subjects with allergic rhinitis who, in
addition, had allergic asthma appeared constant over time
(Table 4). Thus, in both surveys, approximately 40% of
subjects reporting ‘rhinitis related to pollen exposure’ also
reported ‘asthma related to pollen exposure’, and approxi-
mately 50% of subjects reporting ‘rhinitis related to dander
exposure’ also reported ‘asthma related to dander expo-
sure’. These findings might suggest that animal dander
allergens are more likely to induce asthma than pollen
allergens. In accordance with this, Plaschke et al. reported
that sensitization to cat showed a stronger association with
asthma and bronchial hyper-reactivity than did sensitiza-
tion to grass or mite (22). The reason for this could be that
pollen allergens are relatively large and therefore less
respirable.
In conclusion, we found a significantly increased
prevalence of allergic asthma symptoms with no significant
age related trend in this adult general population. The
validity of the allergic asthma symptoms in relation to
specific IgE positivity also changed over time, and some
caution should therefore be exercised in the interpretion
of the results. However, the finding that the positive
predictive values were reasonably stable over time, may
support that the increased prevalence of allergic asthma
symptoms reflects a true increase in allergic asthma.
Considering these results, we fear that asthma continues
to increase, and that this increase is not limited to children
in affected populations.
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